论文标题
通过自动语音分析评估帕金森氏病药状态
Assessment of Parkinson's Disease Medication State through Automatic Speech Analysis
论文作者
论文摘要
帕金森氏病(PD)是一种以运动和非运动症状为特征的中枢神经系统的进行性退行性疾病。随着疾病的发展,由于药物摄入量(在状态)和运动并发症(不在状态)时,患者会减轻运动症状的交替期。目前,患者在关闭状态上花费的时间是评估药理干预措施并评估不同主动原理的疗效的主要参数。在这项工作中,我们提出了一个结合自动语音处理和深度学习技术的系统,通过利用基于个人言语的生物标志物来对PD患者的药物进行分类。我们设计了一种依赖说话者的方法,并研究了不同声学宽松特征集的相关性。结果表明,在半自发性语音任务中,测试任务中的精度为90.54%,精度为95.27%。总体而言,实验评估表明,这种方法在开发可靠的,远程监测和调度PD患者药物摄入量的潜力。
Parkinson's disease (PD) is a progressive degenerative disorder of the central nervous system characterized by motor and non-motor symptoms. As the disease progresses, patients alternate periods in which motor symptoms are mitigated due to medication intake (ON state) and periods with motor complications (OFF state). The time that patients spend in the OFF condition is currently the main parameter employed to assess pharmacological interventions and to evaluate the efficacy of different active principles. In this work, we present a system that combines automatic speech processing and deep learning techniques to classify the medication state of PD patients by leveraging personal speech-based bio-markers. We devise a speaker-dependent approach and investigate the relevance of different acoustic-prosodic feature sets. Results show an accuracy of 90.54% in a test task with mixed speech and an accuracy of 95.27% in a semi-spontaneous speech task. Overall, the experimental assessment shows the potentials of this approach towards the development of reliable, remote daily monitoring and scheduling of medication intake of PD patients.